Press Releases

SAN DIEGO, Jan. 9, 2020 /PRNewswire/ -- Maravai LifeSciences, a global provider of life science reagents and services to researchers and biotech partners, today announced that Gregory T. Lucier has been elected to its board of directors.

LONDON, Jan. 9, 2020 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, childhood-onset neurogenetic disorders with limited or no treatment options, today announced the initiation of patient enrollment in the company's planned pivotal clinical trial for AMO-02 in the treatment of congenital myotonic dystro

SAN FRANCISCO, Jan. 9, 2020 /PRNewswire/ -- OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), announced that Michael Chang, Ph.D. Chairman and CEO, will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 1

ROSEMONT, Ill., Jan. 9, 2020 /PRNewswire/ -- Surgery that moves the jaws forward can result in significant improvements in long-term quality of life – including functional outcomes and sleep quality – in patients with obstructive sleep apnea (OSA), according to a new study.Researchers analyzed long-term quality of life factors in patients who unde

LAKE BUENA VISTA, Fla. and BLOOMFIELD, Conn., Jan. 9, 2020 /PRNewswire/ -- Cigna returns as the proud sponsor of the Walt Disney World® Marathon Weekend, one of the largest marathon race weekends in the United States. More than 60,000 people will race through the park's

XIAMEN, China, Jan. 9, 2020 /PRNewswire/ -- "Falling in love with a city while running". The 2020 C&D Xiamen Marathon started at 7:30 a.m. on January 5, with 35,071 runners having qualified, and 29,805 of them joining the event in the flesh. Runners from 41 countries and regions participated in the

LONDON and CAMBRIDGE, England, Jan. 9, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group / LSE: HIK / NASDAQ Dubai: HIK / OTC: HKMPY) (rated Ba1/stable Moody's and BB+/positive S&P), the multinational generic pharmaceutical company, and Arecor Ltd, the biopharmaceutical company advancing today's therapies to enable healthie

The 12th global licensing partnership for WuXiBody™ since its launch in August 2018 showcasing the power and versatile applications of WuXiBody™ in multiple therapeutic areas SHANGHAI and BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi

CAMPBELL, Calif., Jan. 8, 2020 /PRNewswire/ -- KDx Diagnostics, Inc. (KDx), announced today that the Food and Drug Administration (FDA) has granted "Breakthrough Device" designation for its URO17™ Bladder Cancer Recurrence Test. This revolutionary new test exploits a novel cancer marker that could dramatically improve the accuracy and sensitivity of non-invasi

SAN CARLOS, Calif. and WASHINGTON, Jan. 8, 2020 /PRNewswire/ -- Today's report concerning improvements in cancer mortality is welcomed news. The recently released